Free Trial

iShares Biotechnology ETF (IBB) News Today

iShares Biotechnology ETF logo
$212.50 -0.93 (-0.44%)
Closing price 11/13/2026 04:00 PM Eastern
Extended Trading
$211.25 -1.25 (-0.59%)
As of 11/13/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

iShares Biotechnology ETF Latest News

The AI Debt Bill Is Coming Due, But Biotech Has Revenue to Show for the Boom
The AI Debt Bill Is Coming Due, But Biotech Has Revenue to Show for the Boom (IBB)
AI infrastructure is being funded with debt and stock sales while biotech companies applying AI are booking revenue, led by Tempus AI, Recursion and iShares Biotechnology...
Laboratory scene with a microscope, glassware, test tubes, and a digital DNA double helix illustration.
Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs
Biotech and pharma stocks, tracked by the iShares Biotechnology ETF, have shown relative strength amid the tech sell-off, with Eli Lilly and Pfizer standing out as top performers.
Sector Update: Healthcare Stocks Lean Lower Premarket Monday
5 Undervalued Oncology Stocks Wall Street Is Overlooking
Sector Update: Healthcare Stocks Decline Monday Afternoon
Healthcare Systems' Liquidity Challenge
iShares Trust - iShares Biotechnology ETF
Illustrated trading room with two silhouetted figures viewing multiple screens showing declining and rising stock charts across tech, utilities, healthcare, and retail sectors.
5 Places Investors Can Hide If the AI Trade Keeps Cracking
As AI stocks face volatility, capital is rotating into biotech, industrials, utilities, consumer staples, and dividend ETFs showing relative strength.
A laptop displaying an upward-trending multi-line stock chart sits on a wooden desk beside a coffee mug and smartphone.
MarketBeat Week in Review – 06/22 - 06/26 (IBB)
SpaceX IPO buzz faded as AI volatility, hotter inflation, and a shortened trading week shifted investor focus toward earnings season...
The Biotech Sector Looks Ready for a Multi-Year Breakout—Here's What to Watch.
The iShares Nasdaq Biotechnology ETF (IBB) is trading just 1.47% below its 52-week high, signaling a potential multi-year sector breakout.
2 Ways to Play the Big Pharma Patent Cliff (IBB)
With hundreds of billions in sales on the line for drugs that will lose their patent exclusivity in the coming years, two biotech ETFs can help capitalize.

Related Videos

The Next Wave of AI Just Started (Most Aren’t Ready)

iShares Biotechnology ETF Media Mentions By Week

iShares Biotechnology ETF Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

IBB
News Sentiment
▼
0.53

0.63
▲
Average

News Sentiment

iShares Biotechnology ETF News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

IBB Articles
This Week
▼
3

1
▲
IBB Articles
Average Week

iShares Biotechnology ETF Trends on MarketBeat

This week vs. last week
New Followers
1
Searches
1
Page Views
1,424
-72%
Get iShares Biotechnology ETF News Delivered to You Automatically

Sign up to receive the latest news and ratings for IBB and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for iShares Biotechnology ETF dated 11/11/2026.
From Our Partners